Latest filing published 18 Jan 2019 for Enzo Biochem INC, €6,554.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Elazar Rabbani: trading record in brief
This profile gathers the share dealings of Elazar Rabbani in Enzo Biochem Inc. In total, 19 filings cover trades dated from 23 January 2007 to 14 January 2019.
On the open market, the record shows 8 purchases worth €63k and 2 sales worth €706k. Netting one side against the other leaves €643k of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 4 share grants and 4 option exercises.
Half of the purchases are above €5,436 and half below.
On 18 January 2019 came the latest disclosure, an option exercise for €6,554 in Enzo Biochem Inc. The last insider purchase was made public on 31 October 2018, 2,931 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Elazar Rabbani
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,782 shares@ US$2.702.1% of flowCommon StockSEC:0000930413-19-000105:0
- 10,000 shares@ US$3.351.7% of flowCommon StockSEC:0000930413-18-003233:0Canonical exit: 27 Jan 2019 (T+90)
- 38,505 shares@ US$2.885.2% of flowCommon StockSEC:0000930413-18-000097:0
- 14,000 shares@ US$7.755.1% of flowCommon StockSEC:0000930413-18-000097:1
- 14,534 shares@ US$7.755.3% of flowCommon StockSEC:0000930413-18-000097:2
- 159,091 shares@ US$3.0023.3% of flowCommon StockSEC:0000930413-17-003652:0
- 72,401 shares@ US$10.0935.7% of flowCommon StockSEC:0000930413-17-003652:1
- 47,302 shares@ US$10.0923.3% of flowCommon StockSEC:0000930413-17-003652:2
- 600 shares@ US$2.28Common Stock, par value $0.01 per shareSEC:0000930413-11-007456:0Canonical exit: 14 Feb 2012 (T+90)
- 6,600 shares@ US$2.28Common Stock, par value $0.01 per shareSEC:0000930413-11-007456:1Canonical exit: 14 Feb 2012 (T+90)
- 5,700 shares@ US$2.29Common Stock, par value $0.01 per shareSEC:0000930413-11-007456:2Canonical exit: 14 Feb 2012 (T+90)
- 3,600 shares@ US$2.29Common Stock, par value $0.01 per shareSEC:0000930413-11-007456:3Canonical exit: 14 Feb 2012 (T+90)
- 2,800 shares@ US$2.30Common Stock, par value $0.01 per shareSEC:0000930413-11-007456:4Canonical exit: 14 Feb 2012 (T+90)
- 100 shares@ US$2.30Common Stock, par value $0.01 per shareSEC:0000930413-11-007456:5Canonical exit: 14 Feb 2012 (T+90)
- 600 shares@ US$2.30Common Stock, par value $0.01 per shareSEC:0000930413-11-007456:6Canonical exit: 14 Feb 2012 (T+90)
- 60,755 shares@ US$5.45Common Stock, par value $0.01 per shareSEC:0000930413-08-005730:0
- 29,406 shares@ US$11.26Common Stock, par value $0.01 per shareSEC:0000930413-08-005730:1
- 10,179 sharesCommon Stock, par value $0.01 per shareSEC:0000930413-07-009531:0
- 15,000 sharesRestricted Stock UnitsSEC:0000930413-07-000593:0
19 of 19 declarations
